Esense Lab is an holistic, in-house R&D based pharmaceutical company, having capabilities extending from single plant
profiling via the formulation of compositions, through to biological and botanical research and validation (cell culture,
animal trials and clinical trials in humans).
Goal is to achieve whole-plant phytochemical profiles of a vast variety of targeted plants. The Company’s
first vertical in the commercialisation of their unique and disruptive technology is via the profiling of cannabis and
terpenes, in one of the most rapidly growing markets world wide.
Combine genetics, mRNA, protein expression and phytochemical profiles to generate one comprehensive
model of each target Plant.
In the future, this approach will be applied by Esense Lab to other lucrative target plants. These may include Ginseng,
Saffron, and other rare medicinal plants or spices.
Alternative to natural occurring resources and ease the pressure of wild populations
of rare plants. Simultaneously, we aim to make the essence of these plants accessible and affordable to the broad
market.
EV ~$8M, MC ~$12M
- Forums
- IPOs
- Esence Lab IPO
Esence Lab IPO
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)